These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19443257)

  • 21. Platelet transfusion practice during dengue fever epidemic.
    Kumar ND; Tomar V; Singh B; Kela K
    Indian J Pathol Microbiol; 2000 Jan; 43(1):55-60. PubMed ID: 12583421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Practice assessment in platelet transfusions].
    Martinaud C; Chastagnet N; Sailliol A; de Jaureguiberry JP; Aguilon P
    Transfus Clin Biol; 2012 Feb; 19(1):25-31. PubMed ID: 22284451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and laboratory factors underlying refractoriness to platelet transfusions.
    Friedberg RC
    J Clin Apher; 1996; 11(3):143-8. PubMed ID: 8915819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy using blood components. Prerequisites, indications and clinical use].
    Glück D; Kubanek B; Ahnefeld FW
    Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003.
    Samama CM; Djoudi R; Lecompte T; Nathan N; Schved JF;
    Minerva Anestesiol; 2006 Jun; 72(6):447-52. PubMed ID: 16682914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet support of patients with hematological malignancies.
    Rebulla P
    Haematologica; 1994; 79(5):460-74. PubMed ID: 7843634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very high users of platelet transfusions in the neonatal intensive care unit.
    Dohner ML; Wiedmeier SE; Stoddard RA; Null D; Lambert DK; Burnett J; Baer VL; Hunt JC; Henry E; Christensen RD
    Transfusion; 2009 May; 49(5):869-72. PubMed ID: 19175546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical aspects of treatment with platelet concentrates.
    Lanzer G
    Acta Anaesthesiol Scand Suppl; 1996; 109():141-3. PubMed ID: 8901986
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombocytopenia in the neonate.
    Roberts I; Stanworth S; Murray NA
    Blood Rev; 2008 Jul; 22(4):173-86. PubMed ID: 18433954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.
    Salama A; Kiesewetter H; Kalus U; Movassaghi K; Meyer O
    Thromb Haemost; 2008 Nov; 100(5):762-5. PubMed ID: 18989518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus and controversies in platelet transfusion.
    Marwaha N; Sharma RR
    Transfus Apher Sci; 2009 Oct; 41(2):127-33. PubMed ID: 19717344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet dosing.
    Schlossberg HR; Herman JH
    Transfus Apher Sci; 2003 Jun; 28(3):221-6. PubMed ID: 12725947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guidelines based on scientific evidence for the application of platelet transfusion concentrates].
    Takami A
    Rinsho Ketsueki; 2018; 59(10):2349-2353. PubMed ID: 30305545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic platelet transfusions.
    Estcourt LJ; Stanworth SJ; Murphy MF
    Curr Opin Hematol; 2010 Sep; 17(5):411-7. PubMed ID: 20601869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients].
    Andreu G; Vasse J; Hervé F; Tardivel R; Semana G
    Transfus Clin Biol; 2007 May; 14(1):100-6. PubMed ID: 17524696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.